United States-based Innova Medical Group Inc announced on Monday that it has named Sean Rogers as the chairman of Innova Medical Group and Todd Malan, MD as its new chief medical officer.
Prior to joining Innova Medical Group, Rogers was the global head of Technology Strategy and Solutions. He was also chief executive officer of Pasaca Capital.
Dr Malan was the senior vice president of clinical research at Quantum Material Corporation. He was previously the chief medical officer for iQuantum Labs, founded the investigational research for adipose derived cell therapies at the Center for Regenerative Cell Medicine, and served as medical director for adipose tissues services at Celebration Stem Cell Labs in Arizona.
Relay Therapeutics wins FDA breakthrough status for zovegalisib in breast cancer treatment
DATROWAY receives US priority review for first-line metastatic triple negative breast cancer
Valneva and Instituto Butantan launch pilot chikungunya vaccination campaign in Brazil
Lupin launches Dasatinib tablets in US market
WuXi Biologics enters into licence and research service agreement with Vertex Pharmaceuticals
Natera submits Signatera CDx PMA to FDA for bladder cancer use
Pharming receives FDA complete response letter for paediatric Joenja application
Astrazeneca Imfinzi perioperative regimen gains positive EU CHMP opinion in early gastric cancer
I Peace generates human iPS cells from NKT cells and offers them for research use
Trace Biosciences' IND application for nerve-specific imaging agent approved by FDA
Frontage expands early phase clinical research capabilities across US and China
AstraZeneca agrees obesity and type 2 diabetes collaboration with CSPC
Ascletis Pharma Inc reports topline results from Phase III open-label study of denifanstat
Innovative Molecules GmbH completes Phase 1 clinical development programme for adibelivir
MicuRx Pharmaceuticals' IND application for MRX-5 cleared by FDA